Teva unveils generic version of Lipitor in UK
The generic version of Pfizer’s Lipitor is indicated for the treatment of hypercholesterolaemia and to prevent cardiovascular disease. The company is launching the product in Teva 360 livery,
The US Food and Drug Administration (FDA) has issued traditional approval to Novartis for Fabhalta (iptacopan), to slow the decline of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk of disease progression.